Page results
-
Ensuring that UCLH staff understand the urgency of the climate crisis and support our net zero programme is crucial if we want to be successful in reaching our goal of net zero carbon emissions by 2031. Our patients must be kept informed of changes and we must work closely with other NHS organisations, including NHS England, if we are to deliver a successful programme. This page documents our progress to date.
-
Well done to everyone who ran to support UCLH in the iconic London Landmarks Half Marathon on 2 April!
-
If you need an assessment by a midwife or doctor that is outside of your routine antenatal appointments you will be invited to attend the Maternal and Fetal Assessment Unit (MFAU).
-
The UCLH@Home service is helping patients like 80-year-old Margaret Stone to continue their recovery in their own home under the care of their hospital team.
-
Cancer surgery at UCLH on Operation Ouch
-
Information about coil embolisations and how endovascular treatment is used to treat cerebral aneurysms.
-
Information about endovascular treatments of AVMs undertaken in the NHNN angiography suite.
-
A new research study at UCLH and UCL will investigate how a rare type of blood cancer develops and what types of treatment may be effective for patients.
-
UCLH research manager Sarah Taylor has won a national leadership award for her work to develop and train research staff.
-
New precision therapy for bile duct cancer extends patients’ lives
File results
-
FOI/2023/0007 - Outpatient activity for 2022
-
FOI/2023/0009 - Procedure volumes/ average costs for portable and stable oxygen concentrator devices
-
FOI/2023/0010 - Bardet-biedle Syndrome patient treatment and diagnosis
-
FOI/2023/0013 - Average waiting times for colonoscopy investigations
-
FOI/2023/0014 - Surgery protocols/ standard operating procedures for a feticide
-
FOI/2023/0018 - A&E attendances/ admissions by patients of no fixed abode
-
FOI/2023/0019 - Public access to water refill stations on your premises
-
FOI/2023/0022 - Guidelines staff follow for patients with disabilities and autism
-
FOI/2023/0226 - Treatment with Nivolumab
-
FOI/2023/0225 - Usage of Dabrafenib + Trametinib in cancer treatment